AMSBIO announce MatriMix – a groundbreaking 3D culture substrate. This pioneering hydrogel sets a new benchmark in the field, containing fully defined components, including medical grade collagens, laminin-511 E8 fragments, and hyaluronic acid. The high lot-to-lot consistency of MatriMix enables researchers to obtain highly reproducible results. MatriMix overcomes the limitations of current 3D substrates, enabling cutting-edge applications such as [...]

Company to host webinar featuring tips for managing large-scale proteomics data  on UK Biobank Research Analysis Platform   MOUNTAIN VIEW, Calif. —  DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced its core platform and Cohort Browser are now optimized for accessing and analyzing large-scale proteomics [...]

NANJING, China -- Vazyme (688105.SH), China's leading biotechnology company, has officially signed a global strategic cooperation agreement with Azenta Life Sciences ("Azenta", Nasdaq: AZTA), which will promote to establish "one-stop" service process for both companies in the fields of next-generation sequencing, automated library preparation, raw material supply, experimental consumables, sample storage and more. Dr. Nie Junwei, General Manager of [...]

New Tapestri® v3 brings a higher number of cells captured and greater standardization and robustness to single-cell DNA and multi-omics workflows to empower customer success SOUTH SAN FRANCISCO, CA – Mission Bio, Inc. the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced breakthrough improvements to the Tapestri® Platform and its core chemistry that enable highly [...]

RNA fusions can be used as biomarkers to identify cancer sub-types and monitor for residual disease SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and CeGaT GmbH, a global provider of sequencing services for research, clinical studies, and [...]

DALLAS, TEXAS – Almaden Genomics has announced its Board of Advisors, a highly regarded group of healthcare leaders from both the public and private sectors with experience in cancer research, presicion medicine, biotechnology, clinical trials, bioinformatics, data visualization, computational analysis, pharmacology, and AI. The Board – which includes Adrian Lee, Ph.D., Samir Courdy; Rayna Herman; Graham [...]

Up to an Additional $46.2 Million Available Through Warrant Exercise Led by Novalis LifeSciences LLC with participation from Northpond Ventures, M-185 Corporation and BroadOak Capital Partners SAN DIEGO -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today announced it has signed a securities purchase [...]

Spectronaut® 18 makes DIA proteomics projects more efficient and scalable than ever for all mass spectrometry instrument types Novel research with TrueDiscovery™ and TrueTarget™ demonstrates the unique capabilities and utility of mass spectrometry proteomics for biomarker and drug discovery Biognosys’ iRT Kit is recommended for real-time system suitability monitoring in combination with the Bruker ProteoScape™ software, [...]

Getinge announces today an agreement to acquire 100% of the shares in High Purity New England, Inc. a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications. “This acquisition is another step in Getinge Life Science strategic journey to further expand our presence in the biopharma segment”, says Eric Honroth, President [...]

A small and efficient ultra-low-temperature freezer for reliable storage of sensitive samples. We are proud to present the UF V 350 as the newest member of our ultra-low-temperature freezer product family: The UF V 350 combines the tried-and-tested advantages of its predecessor models, the UF V 500 and UF V 700, and further shines with a considerably [...]